companydata.dkcompanydata.dk

CLINTEC INTERNATIONAL DENMARK ApS: Financial statements 2020

CVR: 31943337

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

CLINTEC INTERNATIONAL DENMARK ApS (CVR 31943337) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 206,920 and a net result of DKK 31,643 compared with DKK 204,095 the year before. That is a decrease of 93.6% compared with the year before. Equity in the 2020 report amounted to DKK 1,159,789. The solvency ratio was 91.8%.

Gross Profit
DKK 206,920
Profit/Loss
DKK 31,643
Equity
DKK 1,159,789
Total Assets
DKK 1,263,640
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-207K32K1.2M0
2019-3.3M204K1.1M4
2018-4.8M218K924K5
2017-4.8M20K706K6
2016-5.5M34K686K5

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is CLINTEC INTERNATIONAL DENMARK ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

CLINTEC INTERNATIONAL DENMARK ApS: The 2019 annual report is outJun 30, 2020

CLINTEC INTERNATIONAL DENMARK ApS has published its annual report for 2019. Gross profit came to DKK 3,254,940, and the net result was DKK 204,095.

Kenneth Arthur Ryttergaard Mikkelsen joins CLINTEC INTERNATIONAL DENMARK ApS as directorApr 8, 2020

As of April 8, 2020, Kenneth Arthur Ryttergaard Mikkelsen is registered as director of CLINTEC INTERNATIONAL DENMARK ApS.

Rabinder Kaur Buttar steps down as director of CLINTEC INTERNATIONAL DENMARK ApSApr 8, 2020

As of April 8, 2020, Rabinder Kaur Buttar has stepped down as director of CLINTEC INTERNATIONAL DENMARK ApS.

About CLINTEC INTERNATIONAL DENMARK ApS

CLINTEC INTERNATIONAL DENMARK ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2009. The company has been dissolved on 26 July 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 1 employee (2020). In 2020, the company reported a gross profit of DKK 206,920 and a net result of DKK 31,643 compared with DKK 204,095 the year before. Equity in the 2020 report amounted to DKK 1,159,789.

Source: annual report 2020, Danish Business Authority